PHILOGEN S.P.A. The Immunotherapy of Cancer Conference(ITOC) is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.
ITOCis organised by the WMA GmbHin scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), theWolfgang Wilmanns Stiftung (WWS), the German Cancer Consortium (DKTK), the Chinese American Hematologist and Oncologist Network (CAHON) as well as the Comprehensive Cancer Center Munich (CCCM)in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
See "Past Conferences"
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Philogen S.p.A. published this content on 18 December 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 December 2023 19:54:31 UTC.
